Oncology Precision Medicine Market: Size, Trends, and Growth Forecast to 2033 The oncology precision medicine industry is experiencing accelerated advancements driven by genomics and targeted therapies, profoundly transforming cancer treatment paradigms globally. Demand for personalized therapeutics is increasing rapidly due to rising cancer prevalence and evolving diagnostic technologies, creating substantial opportunities for innovation and business growth. Market Size and Overview The Global Oncology Precision Medicine Market size is estimated to be valued at USD 190.50 billion in 2026 and is expected to reach USD 366.53 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033. This robust market forecast reflects strong adoption of biomarker-driven therapies and advancements in molecular diagnostics. The oncology precision medicine market report underscores growing investments in R&D and integration of AI technologies, which are driving industry size expansion and enhancing treatment efficacy. Read This Blog Our Web Site : https://www.coherentmarketinsights.com/industry-reports/oncology-precision-medicine-market #GenomicMedicine #MolecularDiagnostics #HealthcareInnovation #MedicalTechnology #MarketResearch #GlobalMarket